AUXL : Analysis & Opinions

  1. Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook

    December 3, 2013
    Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook
  2. Lilly/Boehringer Candidate Under EU Review - Analyst Blog

    July 9, 2013
    The companies are looking to get LY2963016 approved for type I and II diabetes under the EMA's biosimilar pathway.
  3. Warner Chilcott Still in Neutral Lane - Analyst Blog

    July 9, 2013
    We recently maintained our Neutral recommendation on Warner Chilcott
  4. Data on Auxilium's Xiaflex - Analyst Blog

    February 7, 2013
    Auxilium Pharmaceuticals, Inc. (AUXL) recently announced that data from the pivotal phase III trials, IMPRESS (The Investigation ...
  5. Repros Delays ZA-301 Study Results - Analyst Blog

    January 31, 2013
    Repros Therapeutics Inc. (RPRX) recently announced that results from the first pivotal study (ZA-301) of Androxal will be ...
  6. Patent Challenge for Auxilium Pharma - Analyst Blog

    January 7, 2013
    Auxilium Pharmaceuticals, Inc. (AUXL) and Xstelos Holdings, Inc. (XTLS) recently received a notice from Upsher-Smith Laboratories, ...
  7. Healthcare Stocks, Including Pharmacyclics, Making Big Moves ...

    December 17, 2012
    On a good day for the market, the Nasdaq has risen 0.5%, the S&P 500 has increased 0.6% and the Dow has moved up 0.5%. The ...
  8. Regeneron Pharmaceuticals and More Big Movers in Healthcare on ...

    December 13, 2012
    The Nasdaq has decreased 0.4%, the S&P 500 has fallen 0.3% and the Dow is down 0.2% on a bad morning for the market. The ...
  9. Onyx Pharmaceuticals Among Healthcare's Biggest Movers on August ...

    August 21, 2012
    The Nasdaq has moved little, the S&P 500 has moved up 0.3% and the Dow has climbed 0.2% after the morning's trading. The ...
  10. Biggest Healthcare Sector Movers, Including SHPG

    July 31, 2012
    After the morning's trading, the Nasdaq is trading up 0.4%, the S&P 500 remains relatively unchanged and the Dow is unchanged. ...
Investing News
  1. 3 Dumb Ways to Borrow Money

    Money — everyone needs it, but not everyone has it. Many people who find themselves in a ...
  2. Infographic - The Lifecycle of a Bond

    Basic information on how Bonds work.
  3. What $200,000 Will Buy In The Atlanta Real Estate Market

    Atlanta housing prices are up from last year, but they're still lower than the national median. ...
  4. Bubble Bursting? Only For Biotech & Internet Stocks

    The recent sluggish performance of U.S. stocks is leading some market watchers to question ...
  5. What $300,000 Will Buy In The Riverside/San Bernardino Real Estate Market

    The median list price for the San Bernardino/Riverside, Calif. market is $292,800, up 24.6% ...
  6. What Is Worse Than Being At Risk?

    You may have heard the old adage: “What is worse than being lost? Not knowing you are lost.” ...
Trading Center